Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DYDROGESTERONE for Ovulation induction: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where DYDROGESTERONE was used for Ovulation induction.

Most Reported Side Effects for DYDROGESTERONE

Side Effect Reports % Deaths Hosp.
Maternal exposure during pregnancy 117 34.4% 2 8
Abortion spontaneous 93 27.4% 0 0
Ovarian hyperstimulation syndrome 34 10.0% 0 28
Foetal exposure during pregnancy 27 7.9% 2 1
Exposure during pregnancy 20 5.9% 0 6
Off label use 18 5.3% 0 13
Meningioma 17 5.0% 0 9
Premature baby 16 4.7% 1 1
Product use in unapproved indication 15 4.4% 0 8
Toxicity to various agents 11 3.2% 0 0
Vaginal haemorrhage 11 3.2% 0 10
Ascites 10 2.9% 0 7
Headache 10 2.9% 0 0
Intentional self-injury 10 2.9% 0 0
Low birth weight baby 10 2.9% 0 1

Other Indications for DYDROGESTERONE

Hormone replacement therapy (99) Product used for unknown indication (48) Assisted reproductive technology (26) In vitro fertilisation (26) Luteal phase deficiency (12) Foetal exposure during pregnancy (9) Intentional self-injury (8) Infertility (6) Abortion spontaneous (5) Amenorrhoea (5)

Other Drugs Used for Ovulation induction

CHORIOGONADOTROPIN ALFA (460) FOLLITROPIN (249) CLOMIPHENE (124) LETROZOLE (122) MENOTROPINS (107) FOLLITROPIN BETA (86) LUTROPIN ALFA (86) TRIPTORELIN (73) LEUPROLIDE (64) GONADOTROPHIN, CHORIONIC (57)

Related Pages

DYDROGESTERONE Full Profile All Ovulation induction Drugs DYDROGESTERONE Demographics DYDROGESTERONE Timeline